登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Alpha-Synuclein】

Alpha-Synuclein信息

英文名称:Synuclein alpha
中文名称:α-突触核蛋白
靶点别称:Truncated Alpha Synuclein,Α-Synuclein,Non-A Beta Component Of AD Amyloid,Synuclein Alpha-140,I+/--Synuclein,α-Synuclein,PARK4,PD1,alpha-Synuclein,Synuclein, Alpha (Non A4 Component Of Amyloid Precursor),Non A-Beta Component Of AD Amyloid,PARK1,SNCA,Synuclein Alpha,NACP,Parkinson Disease (Autosomal Dominant, Lewy Body) 4,Non-A4 Component Of Amyloid Precursor,Non A4 Component Of Amyloid Precursor
上市药物数量:0
临床药物数量:20
最高研发阶段:临床三期

Alpha-Synuclein分子别名

SNCA,NACP,PARK1,alpha-Synuclein

Alpha-Synuclein分子背景

Alpha-synuclein is a neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. It acts also as a molecular chaperone in its multimeric membrane-bound state, assisting in the folding of synaptic fusion components called SNAREs (Soluble NSF Attachment Protein REceptors) at presynaptic plasma membrane in conjunction with cysteine string protein-alpha/DNAJC5. Abnormalities in alpha-synuclein are implicated in the pathogenesis of Parkinson's disease (PD). Alpha-synuclein is present in Lewy-bodies, the neuropathological hallmark of PD, and the protein and its aggregation have been widely linked to neurotoxic pathways that ultimately lead to neurodegeneration.

Alpha-Synuclein临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定